Tryptamine Therapeutics is edging closer to first patient dosing in its world-first clinical trial for binge eating disorder ...

Summit Biotech Fund backs opportunities in the ASX healthcare space and sees upside in three particular names including ...

The healthcare sector rose 9.05% in July to be the best of the 11 ASX sectors. A turn up for the books to be sure. While ...

Fibromyalgia, a complex chronic pain disorder marked by widespread pain, fatigue, and cognitive issues, is witnessing evolving treatment advancements ...

With warmer temperatures, ticks have been taking root in places they never have before. Now, Canadian scientists are trying ...

There is a shortage of some commonly-prescribed painkillers in Canada — including acetaminophen with codeine and ...

Canadians are living longer than ever before, with average life expectancy now exceeding 84 years for women and 80 for men, ...

Montreal researchers say they’ve made a breakthrough discovery in understanding a poorly understood illness – chronic fatigue ...

Tryptamine has kicked off its world-first Binge Eating Disorder trial with psilocin, with dosing around the corner and potential to ... Read More The post Tryptamine opens patient recruitment for ...